Rubric Assessments (626384)
Assessment | Metrics | Date | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Target | Project | Contact information is provided for the creator(s) of the dataset. | Globally unique identifier | Machine-readable metadata | Standardized metadata | Resource identifier in metadata | Open, Free, Standardized Access protocol | Digital resource license | Metadata license | NIH program name is available for querying | NIH project name is available for querying | The institution that created this dataset is available | A biological assay is present and resolvable in CFDE-specified ontology (OBI) | A relevant anatomical part is present and resolvable in the UBERON Ontology | A relevant disease is present and resolvable in the MONDO Ontology | A relevant file type is present and resolvable in the EDAM Ontology | A relevant taxonomy is present and resolvable in the NCBITaxon Ontology | A relevant cell line is present and resolvable in the Cellosaurus Ontology | A landing page exists and is accessible | ||
Abemaciclib KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
CP-690550 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
5z-7-oxozeaenol KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
CI-1040 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
CG-930 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
AZD-1152HQPA KINOMEscan-2 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
AG1478 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
CGP74514A KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
BEZ235 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Breast Cancer Profiling Project - Proteomics 2: 1 phosphoproteome dataset (including phosphotyrosine enrichment) for a 35-cell line breast cancer panel under basal conditions | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.84) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Dinaciclib KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Aggregated ChEMBL bioactivity data (v20) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yesbut (0.76) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Aggregated Tox21 bioactivity data | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.84) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
CI-1033 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
BMS-540215 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
AZ-628 KiNativ -- dose response experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yesbut (0.76) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
BIBW-2992 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
ALW-II-38-3 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
BYL719 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Cell signaling response to cytokines measured by high throughput microscopy | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yesbut (0.76) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
AC220 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
BMS-536924 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Average variable importance in the projection (VIP) scores from the PLSR models analyzing the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.84) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
BMS-387032 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 |